NY-ESO-1 and MAGE-A4 have been found to be expressed in synovial sarcoma (49–88%) and myxoid/round cell liposarcoma (35–100%) and suggested to be involved in the pathogenesis of these diseases [16,18,19,25,27]. The gene discussed is MAGEA4; the disease is myxoid/round cell liposarcoma.